Disrupting normative science has become a de rigueur component of the pharmaceutical industry business model. A new pharmaceutical product is not based on need, it is based on market size and profitability. When new data threatens the market of a pharmaceutical product, then that pharma company will try to sprout the seeds of scientific uncertainty and lack of proof.
Dr Robert Malone
#health #disease #cancer #diabetes #natural-health #Big-Pharma
Recently, inositols, especially myo-inositol and inositol hexakisphosphate, also known as phytic acid or IP6, with their biological activities received much attention for their role in multiple health beneficial effects. Although their roles in cancer treatment and prevention have been extensively reported, interestingly, they may also have distinctive properties in energy metabolism and metabolic disorders. We review inositols and inositol phosphate metabolism in mammalian cells to establish their biological activities and highlight their potential roles in energy metabolism. These molecules are known to decrease insulin resistance, increase insulin sensitivity, and have diverse properties with importance from cell signaling to metabolism. Evidence showed that inositol phosphates might enhance the browning of white adipocytes and directly improve insulin sensitivity through adipocytes. In addition, inositol pyrophosphates containing high-energy phosphate bonds are considered in increasing cellular energetics.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663797/
